Dr Alicia Galdon

Research Associate

View graph of relations


Following completion of my BSc in Biomedical Sciences at the University of Manchester, including one year industrial experience in Investigative and Translational Pathology at AstraZeneca UK, I then undertook a PhD in Immunology under the supervision of Professor Andrew MacDonald, and I am currently a Postdoctoral Research Associate in the same laboratory.

My specific research interests lie in the field of cancer immunotherapy, and my research aims to elucidate the mechanism by which a novel mycobacterial co-therapy, IMM-101, enhances tumour cell killing and prolongs surivival in patients with advanced pancreatic (and other) cancers.  Specifically, this rearch aims to discover the following:

  • What immune cell types are preferentially activated by IMM-101 both local and distal to the injection site?
  • By what mechanism is the local immune reaction translated to a systemic immune response?
  • Does IMM-101 enhance tumour immune cell infiltration?

Memberships of committees and professional bodies

British Society for Immunology - 2017 to present.

Areas of expertise

Sustainable Development Goals

Education / academic qualifications

  • 2016 - Bachelor of Science, Biomedical Sciences with Industrial Experience , The University of Manchester

Related information